DNA- and RNA-aptamers binding the soluble interleukin-6-receptor
The invention concerns DNA- and RNA-aptamers with high affinity and specificity for the human soluble IL-6-receptor with no or very low immunogenicity. These aptamers are very promising substances to treat or prevent diseases involving the IL-6-receptor, such as inflammation, cancer or infections. Furthermore, they can be easily and cost-efficiently produced and stored.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Breakthrough in magnetism that could transform quantum computing and superconductors
Researchers discover new magnetic and electronic properties in kagome magnet thin films. A discovery by Rice University physicists and collaborators is unlocking a new understanding of magnetism and electronic interactions…
NASA to launch innovative solar coronagraph to Space Station
NASA’s Coronal Diagnostic Experiment (CODEX) is ready to launch to the International Space Station to reveal new details about the solar wind including its origin and its evolution. Launching in…
Boosting efficiency in mining with AI and automation
“Doing instead of procrastinating”. This is the AI strategy presented by Prof. Constantin Haefner, Director of the Fraunhofer Institute for Laser Technology ILT, at the “AKL’24 – International Laser Technology…